HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Non-radioactive protein lysine methyltransferase microplate assay based on reading domains.

Abstract
New protein lysine methyltransferase (PKMT) assays are needed to facilitate screening for improved PKMT inhibitors, because PKMTs are mutated or overexpressed in several cancers. In cells, methylated lysine residues are recognized by reading domains such as the chromodomain of HP1β, which bind to target proteins in a lysine-methylation-specific manner. Herein we describe a sensitive, robust, and non-radioactive high-throughput PKMT assay that employs the HP1β chromodomain to detect the methylation of peptide substrates by the human SUV39H1 and SUV39H2 PKMTs. The assay has a very good dynamic range and high signal-to-noise ratio. It can be used to screen for PKMT inhibitors, as illustrated by analyzing the inhibition of SUV39H1 by chaetocin. The IC50 value of this inhibition was found to be 480 nM, which is close to its published value. Our data indicate that natural reading domains can be used as alternates to methyl-specific antibodies in PKMT assays. Reading domains can be produced recombinantly in E. coli at low cost and consistent quality, and they are accessible to protein design.
AuthorsSrikanth Kudithipudi, Denis Kusevic, Albert Jeltsch
JournalChemMedChem (ChemMedChem) Vol. 9 Issue 3 Pg. 554-9 (Mar 2014) ISSN: 1860-7187 [Electronic] Germany
PMID23671032 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Chemical References
  • CBX1 protein, human
  • Piperazines
  • Chromobox Protein Homolog 5
  • chaetocin
  • Histone-Lysine N-Methyltransferase
Topics
  • Chromobox Protein Homolog 5
  • Enzyme Assays (methods)
  • Histone-Lysine N-Methyltransferase (analysis, antagonists & inhibitors, metabolism)
  • Humans
  • Inhibitory Concentration 50
  • Piperazines (chemistry, pharmacology)
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: